NSE BSE
sequent scientific ltd. stock

SEQUENT SCIENTIFIC LTD. Share Price

- - (%)
- NSE: SEQUENT

SEQUENT SCIENTIFIC LTD. Share Price Update

As of the latest trading session, SEQUENT SCIENTIFIC LTD. share price is currently at 140.27, which is down by -4.59 from its previous closing. Today, the stock has fluctuated between 132.16 and 146.49. Over the past year, SEQUENT SCIENTIFIC LTD. has achieved a return of 57.01 %. In the last month alone, the return has been 15.98 %. Read More...

SEQUENT SCIENTIFIC LTD. Performance

Day Range

Low132.16 High146.49
140.92

52 Week Range

Low 86.40 High 155.50
140.92

SEQUENT SCIENTIFIC LTD. Share Price

14296

512529

SEQUENT

img img img img
No Data Available

Open Price

144.00

Prev. Close

144.87

Volume (Shares)

1507849.00

Total traded value

2124.86

Upper Circuit

173.84

Lower Circuit

115.89

Note: The current prices & values are delayed, Login to your account for live updates.

SEQUENT SCIENTIFIC LTD. Fundamentals


(Standalone)

Market Cap (Cr) 3498.80
PE Ratio (TTM) 7052.50
Book Value / Share 43.57
Beta 0.95
ROE -0.58%
EPS (TTM) 0.26
Dividend Yield 0.00%
Net Profit Qtr (Cr) 3.76

SEQUENT SCIENTIFIC LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 36.77
Operating Expense 45.65
Net Profit 3.76
Net Profit Margin (%) 10.22
Earnings Per Share (EPS) 0.15
EBITDA 7.24
Effective Tax Rate (%) 8.29
Particulars DEC 2023 (Values in Cr)
Revenue 42.21
Operating Expense 49.55
Net Profit 4.58
Net Profit Margin (%) 10.85
Earnings Per Share (EPS) 0.18
EBITDA 9.29
Effective Tax Rate (%) 24.79
Particulars SEP 2023 (Values in Cr)
Revenue 49.12
Operating Expense 60.38
Net Profit -0.92
Net Profit Margin (%) -1.87
Earnings Per Share (EPS) -0.04
EBITDA 2.16
Effective Tax Rate (%) 34.28
Particulars JUN 2023 (Values in Cr)
Revenue 40.42
Operating Expense 52.90
Net Profit -6.80
Net Profit Margin (%) -16.82
Earnings Per Share (EPS) -0.27
EBITDA -5.61
Effective Tax Rate (%) 24.69
Particulars MAR 2023 (Values in Cr)
Revenue 46.60
Operating Expense 55.83
Net Profit -1.65
Net Profit Margin (%) -3.54
Earnings Per Share (EPS) -0.07
EBITDA 1.97
Effective Tax Rate (%) -34.14
Particulars MAR 2024 (Values in Cr)
Revenue 168.52
Operating Expense 208.48
Net Profit 0.62
Net Profit Margin (%) 0.36
Earnings Per Share (EPS) 0.03
EBITDA 13.05
Effective Tax Rate (%) 358.33
Particulars MAR 2023 (Values in Cr)
Revenue 222.69
Operating Expense 260.67
Net Profit -6.08
Net Profit Margin (%) -2.73
Earnings Per Share (EPS) -0.24
EBITDA 1.87
Effective Tax Rate (%) 37.64
Particulars MAR 2022 (Values in Cr)
Revenue 219.63
Operating Expense 231.58
Net Profit 14.80
Net Profit Margin (%) 6.73
Earnings Per Share (EPS) 0.60
EBITDA 26.89
Effective Tax Rate (%) 5.67
Particulars MAR 2021 (Values in Cr)
Revenue 265.46
Operating Expense 241.97
Net Profit 32.11
Net Profit Margin (%) 12.09
Earnings Per Share (EPS) 1.30
EBITDA 52.70
Effective Tax Rate (%) 21.44
Particulars MAR 2020 (Values in Cr)
Revenue 227.33
Operating Expense 219.09
Net Profit 21.34
Net Profit Margin (%) 9.38
Earnings Per Share (EPS) 0.88
EBITDA 36.80
Effective Tax Rate (%) 6.44
Particulars MAR 2023 (Values in Cr)
Book Value / Share 28.01
ROE % -9.04
ROCE % -3.52
Total Debt to Total Equity 0.58
EBITDA Margin 1.14
Particulars MAR 2022 (Values in Cr)
Book Value / Share 27.50
ROE % 6.31
ROCE % 6.57
Total Debt to Total Equity 0.45
EBITDA Margin 8.51
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.30
ROE % 13.98
ROCE % 14.62
Total Debt to Total Equity 0.44
EBITDA Margin 15.54
Particulars MAR 2020 (Values in Cr)
Book Value / Share 27.66
ROE % 10.17
ROCE % 10.78
Total Debt to Total Equity 0.48
EBITDA Margin 15.30
Particulars MAR 2019 (Values in Cr)
Book Value / Share 28.63
ROE % 6.76
ROCE % 7.41
Total Debt to Total Equity 0.46
EBITDA Margin 12.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 41.74
Total Assets 1529.12
Total Liabilities 1529.12
Total Equity 749.19
Share Outstanding 249433495
Price to Book Ratio 1.71
Return on Assets (%) -7.92
Return on Capital (%) -10.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 59.25
Total Assets 1450.97
Total Liabilities 1450.97
Total Equity 740.10
Share Outstanding 248370995
Price to Book Ratio 3.22
Return on Assets (%) 2.82
Return on Capital (%) 3.88
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 56.19
Total Assets 1392.55
Total Liabilities 1392.55
Total Equity 776.31
Share Outstanding 248370995
Price to Book Ratio 5.81
Return on Assets (%) 6.85
Return on Capital (%) 9.53
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 75.82
Total Assets 1462.64
Total Liabilities 1462.64
Total Equity 731.84
Share Outstanding 248370995
Price to Book Ratio 2.18
Return on Assets (%) 4.77
Return on Capital (%) 6.79
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 72.03
Total Assets 1387.87
Total Liabilities 1387.87
Total Equity 746.94
Share Outstanding 246870995
Price to Book Ratio 1.93
Return on Assets (%) 3.50
Return on Capital (%) 4.76
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 1122.77
Total Liabilities 1122.77
Total Equity 1058.36
Share Outstanding 249433495
Price to Book Ratio 1.71
Return on Assets (%) -0.54
Return on Capital (%) -0.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.88
Total Assets 1124.23
Total Liabilities 1124.23
Total Equity 1041.08
Share Outstanding 248370995
Price to Book Ratio 3.22
Return on Assets (%) 1.31
Return on Capital (%) 1.4
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.74
Total Assets 1102.12
Total Liabilities 1102.12
Total Equity 1029.51
Share Outstanding 248370995
Price to Book Ratio 5.81
Return on Assets (%) 2.91
Return on Capital (%) 3.1
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.71
Total Assets 997.37
Total Liabilities 997.37
Total Equity 886.21
Share Outstanding 248370995
Price to Book Ratio 2.18
Return on Assets (%) 2.13
Return on Capital (%) 2.33
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 1.87
Total Assets 1018.89
Total Liabilities 1018.89
Total Equity 917.79
Share Outstanding 246870995
Price to Book Ratio 1.93
Return on Assets (%) 0.74
Return on Capital (%) 0.79
Particulars MAR 2023 (Values in Cr)
Net Income -137.65
Cash from Operations 31.45
Cash from Investing -64.95
Cash from Financing 32.22
Net change in Cash -15.92
Free Cash Flow 117.63
Particulars MAR 2022 (Values in Cr)
Net Income 52.93
Cash from Operations 57.36
Cash from Investing -95.56
Cash from Financing 67.25
Net change in Cash 2.28
Free Cash Flow 89.82
Particulars MAR 2021 (Values in Cr)
Net Income 145.45
Cash from Operations 158.54
Cash from Investing 9.64
Cash from Financing -138.75
Net change in Cash -14.35
Free Cash Flow 211.37
Particulars MAR 2020 (Values in Cr)
Net Income 94.07
Cash from Operations 127.18
Cash from Investing -72.27
Cash from Financing -42.75
Net change in Cash 0.30
Free Cash Flow 167.90
Particulars MAR 2019 (Values in Cr)
Net Income 58.88
Cash from Operations 115.40
Cash from Investing -67.69
Cash from Financing -20.08
Net change in Cash 28.24
Free Cash Flow 140.84
Particulars MAR 2023 (Values in Cr)
Net Income -9.74
Cash from Operations 38.44
Cash from Investing -50.70
Cash from Financing 0.24
Net change in Cash -12.71
Free Cash Flow 47.30
Particulars MAR 2022 (Values in Cr)
Net Income 15.69
Cash from Operations 11.11
Cash from Investing -4.24
Cash from Financing 7.24
Net change in Cash 12.36
Free Cash Flow 17.56
Particulars MAR 2021 (Values in Cr)
Net Income 43.44
Cash from Operations 19.09
Cash from Investing 16.55
Cash from Financing -21.32
Net change in Cash -2.43
Free Cash Flow 28.61
Particulars MAR 2020 (Values in Cr)
Net Income 22.81
Cash from Operations 32.39
Cash from Investing -17.68
Cash from Financing -10.71
Net change in Cash 1.80
Free Cash Flow 37.78
Particulars MAR 2019 (Values in Cr)
Net Income 6.20
Cash from Operations 74.33
Cash from Investing -114.06
Cash from Financing 40.33
Net change in Cash 0.07
Free Cash Flow 77.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
SEQUENT SCIENTIFIC LTD. 141.05 0.00 5.35 3518.93 86.03 / 155.45
BLISS GVS PHARMA LTD 110.15 12.05 1.19 1155.28 77.65 / 148.95
CIPLA LTD 1485.15 28.17 4.49 119928.54 1028.00 / 1581.70
FERMENTA BIOTECH LIMITED 229.35 0.00 2.33 675.00 137.10 / 262.00
GLAXOSMITHKLINE PHARMA LT 2570.70 66.32 24.49 43549.21 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
SEQUENT SCIENTIFIC LTD. 141.05 0.00 3.23 3518.93 86.03 / 155.45
AMRUTAJAN HEALTH LTD 738.70 47.47 7.40 2135.63 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6349.65 106.48 22.29 15874.13 3730.00 / 7550.00
BLISS GVS PHARMA LTD 110.15 15.17 1.16 1155.28 77.65 / 148.95
ABBOTT INDIA LIMITED 27407.65 48.49 15.74 58241.26 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 141.70
  • 26 Days 130.70
  • 10 Days 138.40
  • 50 Days 124.40
  • 12 Days 136.50
  • 100 Days 126.30
  • 20 Days 132.60
  • 200 Days 98.30
144.15
PIVOT
First Resistance 147.65
Second Resistance 153.20
Third Resistance 156.70
First Support 138.60
Second Support 135.10
Third Support 129.55
RSI 72.47
MACD 5.78
Commodity Channel Index (CCI) 90.40
ADX 40.40
Williams % R -26.69

Over 1 Month

down

15.98

Over 3 Months

down

17.92

Over 6 Months

down

2.56

Over 1 Year

down

57.01

Over 3 Years

down

-23.33

Over 5 Years

down

16.06

SEQUENT SCIENTIFIC LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SEQUENT SCIENTIFIC LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
35.83
Promoter Holdings
52.78
FII
5.69
DII
5.68
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ca Harbor Investments Shareholding of Promoter and Promoter Group 1.31680103E8 52.78
Quant Mutual Fund - Quant Healthcare Fund Public Shareholding 1.3128366E7 5.26
Unit Trust Of India Investment Advisory Services L Public Shareholding 8309763.0 3.33
Ashoka Whiteoak Icav - Ashoka Whiteoak India Oppor Public Shareholding 4078604.0 1.63

SEQUENT SCIENTIFIC LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2021-09-08 0.5 Final 2021-09-10 Equity shares 2019-08-21 0.2 Final 2019-08-23 Equity shares 2017-11-20 0.2 Interim 2017-11-21 Equity shares 2011-09-16 1.5 Final 2011-09-20 Equity shares 2010-09-23 2.0 Final 2010-09-27 Equity shares 2009-09-02 1.0 Final 2009-09-04 Equity shares 2008-09-11 1.0 Final 2008-09-15 Equity shares 2007-09-13 1.0 Final 2007-09-17 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2016-02-25 10.0 2.0 2016-02-26

Learn More About Stocks

About SEQUENT SCIENTIFIC LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SEQUENT SCIENTIFIC LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Sequent Scientific Ltd?

Answer Field

The share price of Sequent Scientific Ltd for NSE is ₹ 140.27 and for BSE is ₹ 140.25.

What is the Market Cap of Sequent Scientific Ltd?

Answer Field

The market cap of Sequent Scientific Ltd for NSE is ₹ 34,98.80 Cr. and for BSE is ₹ 34,98.30 Cr. as of now.

What is the 52 Week High and Low of Sequent Scientific Ltd?

Answer Field

The 52 Week High and Low of Sequent Scientific Ltd for NSE is ₹ 155.50 and ₹ 86.40 and for BSE is ₹ 155.45 and ₹ 86.03.

How to Buy Sequent Scientific Ltd share?

Answer Field

You can trade in Sequent Scientific Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sequent Scientific Ltd?

Answer Field

The 1 year returns on the stock has been 57.01%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader